Atlas Trials

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Clinical trial NCT03533920 · COMPLETED

Trial details

NCT number
NCT03533920
Sponsor
Jeil Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma Non-resectable
Start date
2017-10-25
Primary completion
2018-06-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.